Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by Sniper007on Jul 07, 2016 5:05pm
106 Views
Post# 25033364

RE:have you guys ever given any thought to the fact that.......

RE:have you guys ever given any thought to the fact that.......
Wow Jeckyl, that was one ill conceived post. "maybe pharma doesn't really want or possibly need, what bioasis does or doesn't have?" You're funny, but not really. "up to now, pharma seem to be satisfied with whatever results they have for transporting therapeutics across the bbb (no agreement with bioasis is the gauge)." Satisfied with what? Please elaborate. "maybe, just maybe, whatever leakage they're getting with their programs is just enough for them to advance internal programs without having to pay the millions or billions possibly trillions, ok, maybe a little over done, to bti? with or without the peptide transporter there may be uptake in the periphery why pay extra for the spillage?" Really Jeckyl? That made me laugh. "before you all jump on me and attempt to reprimand or chastise me, why don't you ask yourselves why there hasn't been a license signed for this revolutionary peptide?" I've asked myself the question and there are many reasons that have been discussed here at length and you've been part of many of those discussions. Are you getting too old to remember those discussions or have you conveniently forgot? Everything points to not 'if', but 'when'. License agreements do take longer than you think - there's too much time and money involved to make an uniformed decision. 250-500 million isn't very much money is it Jeckyl? Ha! And yes, it can take 9 months or more (again all discussed here at length). I also think there's a real possibility the drugs the pharmas have tested need to be re-engineered for further evaluation, or it's possible they don't work at all as well as hoped. If that is the case, yes, the pharmas got that info. for next to nothing but we already know LSD enzymes work when delivered to the brain. I'll wait on that deal. Over 14 players involved according to RH Somebody wants it and somebody's gonna pay for it. Who's it going to be? I don't really care! Sniper
Bullboard Posts